Datasheet

Gordonibacter urolithinfaciens; 27213 (CAT#: LBST-083FG)

Gordonibacter urolithinfaciens was isolated from human feces of a healthy volunteer. It is a Gram-positive bacteria belonging to the recent family Eggerthellaceae.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Product Information
Product Overview Gordonibacter urolithinfaciens was isolated from human feces of a healthy volunteer. It is a Gram-positive bacteria belonging to the recent family Eggerthellaceae.
Target Eggerthellaceae
Genus Gordonibacter
Application Study and research
Culture Medium PYG medium
Culture Conditions 37°C; Anaerobic
Source Human faeces of a healthy volunteer
Risk Group 2
Product Format Freeze-dried
Packaging Ampoule tube
Storage -80°C
Shelf Life 6 years
Target Introduction
Introduction The Eggerthellaceae are a family of Gram-positive, rod- or coccus-shaped Actinobacteria. It is the sole family within the order Eggerthellales. Members of this family are mostly anaerobic, non-motile, asaccharolytic and do not form spores. Eggerthellaceae species are commonly isolated from human and animal faeces and other human sources such as the colon, vagina, oral cavity and blood.
Alternative Names Gordonibacter urolithinfaciens; 27213
FAQs Customer Reviews Related Products
  1. What are the ideal culturing conditions for Gordonibacter urolithinfaciens; 27213?

    Gordonibacter urolithinfaciens; 27213 should be cultured under anaerobic conditions at 37°C using a nutrient-rich medium such as Medium 104. This ensures optimal growth and viability, providing reliable results for experimental purposes.

  2. How can the metabolic activity of Gordonibacter urolithinfaciens; 27213 be studied?

    The metabolic activity of Gordonibacter urolithinfaciens; 27213 can be studied using techniques like gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC) to analyze the production of urolithins and other metabolites. These methods help understand its metabolic pathways.

  3. What methods are used to quantify Gordonibacter urolithinfaciens; 27213 in experimental samples?

    Quantification of Gordonibacter urolithinfaciens; 27213 can be achieved using quantitative PCR (qPCR) targeting specific genetic markers or by colony-forming unit (CFU) counts on selective media. These methods provide accurate measurements of bacterial presence and concentration.

  4. How is the viability of Gordonibacter urolithinfaciens; 27213 maintained during storage?

    To maintain viability, Gordonibacter urolithinfaciens; 27213 should be stored at -80°C in cryoprotectant solutions such as glycerol. Ensuring a stable cold chain during storage and transportation is crucial to preserving the bacterial strain's integrity and functionality for future research.

  5. How can the probiotic effects of Gordonibacter urolithinfaciens; 27213 be evaluated in vitro?

    The probiotic effects of Gordonibacter urolithinfaciens; 27213 can be evaluated in vitro using co-culture systems with intestinal cell lines. Researchers can monitor changes in cell viability, cytokine production, and barrier function to assess the bacterium's beneficial properties.

  • Precision in Microbiome Studies
    Gordonibacter urolithinfaciens; 27213 from Creative Biolabs provided precise and reliable data in our microbiome research, making it an invaluable asset in our experimental workflows.
  • Enhanced Data Accuracy
    Using Gordonibacter urolithinfaciens; 27213 significantly enhanced the accuracy of our microbial interaction studies, outperforming other available products.
  • Reliable Experimental Results
    Gordonibacter urolithinfaciens; 27213 consistently delivered reliable results in our drug metabolism research, setting a new standard in our laboratory.
  • Enhanced Study Reliability
    The reliability of Gordonibacter urolithinfaciens; 27213 in our drug discovery experiments was exceptional, providing dependable data for our research team.
  • Optimal Experimental Outcomes
    Gordonibacter urolithinfaciens; 27213 facilitated optimal experimental outcomes in our microbiome research, making it a preferred choice for our studies.

Click the button below to contact us or submit your feedback about this product.


Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket
Advertisement